基本信息
浏览量:0
职业迁徙
个人简介
Dr. Wenzhi Tian is the founder and Chairman of ImmuneOnco Biopharma Co., Ltd, a
clinical stage biotech company headquartered in Shanghai, China, with primary focus
on research and development of tumor immunotherapeutic drugs including checkpoint
modulators and target-activated NK (TANKTM) products. Prior to ImmuneOnco
Biopharma, Dr. Tian worked as Chief Executive Officer at Huabo Biopharm from
June of 2011 to April of 2015. During that period, Dr. Tian advanced two large
molecule programs to the clinical stage. Prior to moving back to China, Dr. Tian
worked as Principal Research Scientist at ImClone Systems from January of 2006 to
April of 2011.
Dr. Tian graduated from Henan Medical University (Now Zhengzhou University
School of Medicine) and did his postdoctoral training at North Shore University
Hospital, NYU School of Medicine. He was appointed a Senior Research Associate at
Weill Medical College of Cornell University thereafter.
研究兴趣
论文共 46 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 7_Supplement (2024)
Rujiao Liu,Xichun Hu,Zhengbo Song,Jian Zhang,Jianan Jin,Shuiping Gao,Yuping Sun, Yan Zhang,Shegan Gao,Ruinuo Jia, Deqiang Jing, Yu Xu, Zhenjiu Wang,Qiying Lu,Wenzhi Tian,Xiangdong Cheng
Journal of Clinical Oncologyno. 16_suppl (2024)
Cancer researchno. 7_Supplement (2024): LB129-LB129
Song Li,Dianze Chen, Yanan Yang,Huiqin Guo,Dandan Liu, Nana Sun,Xing Bai, Kaili Wang, Tengfei Li, Guanghui Li,Chunmei Yang, Wei Zhang, Li Zhang,Gui Zhao,Liang Peng,Sijin Liu,Xiaoping Tu,Ruliang Zhang,Wenzhi Tian
Cancer Immunology, Immunotherapyno. 2 (2024): 1-11
Binglei Zhang,Jianxiang Shi,Xiaojing Shi, Xiaolu Xu, Le Gao,Song Li,Mengmeng Liu, Mengya Gao,Shuiling Jin,Jian Zhou,Dandan Fan,Fang Wang, Zhenyu Ji,Zhilei Bian,Yongping Song,Wenzhi Tian,Yichao Zheng,Linping Xu,Wei Li
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy (2024): 101068-101068
Dianze Chen,Song Li, Yanan Yang,Dandan Liu,Chunmei Yang,Huiqin Guo,Xing Bai, Li Zhang,Ruliang Zhang,Wenzhi Tian
Journal of pharmaceutical and biomedical analysis (2024): 116431-116431
Cancer researchno. 7_Supplement (2024): CT173-CT173
Song Li,Dianze Chen,Huiqin Guo,Dandan Liu,Chunmei Yang,Ruliang Zhang, Tianxiang Wang, Fan Zhang,Xing Bai,Yanan Yang, Nana Sun, Wei Zhang,Li Zhang,Gui Zhao,Liang Peng,Xiaoping Tu,Wenzhi Tian
Frontiers in oncology (2023): 1240061
加载更多
作者统计
#Papers: 47
#Citation: 516
H-Index: 9
G-Index: 20
Sociability: 5
Diversity: 2
Activity: 35
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn